Patents by Inventor Pradyot Nandi

Pradyot Nandi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230007972
    Abstract: The present invention relates generally to the field of immunogenic compositions containing volatile salts. In certain embodiments, compositions and methods disclosed herein relate to producing and using novel combinations to create frozen immunogenic agents bound to adjuvant having improved formulations and improved consistency of distribution of adjuvant for storage and subsequent delivery to a subject in need thereof.
    Type: Application
    Filed: April 28, 2022
    Publication date: January 12, 2023
    Inventors: Kimberly Hassett, Pradyot Nandi, John Carpenter, Theodore Randolph
  • Patent number: 11491111
    Abstract: The present invention relates generally to the field of immunogenic compositions containing volatile salts. In certain embodiments, compositions and methods disclosed herein relate to producing and using novel combinations to create frozen immunogenic agents bound to adjuvant having improved formulations and improved consistency of distribution of adjuvant for storage and subsequent delivery to a subject in need thereof.
    Type: Grant
    Filed: June 21, 2019
    Date of Patent: November 8, 2022
    Assignee: The Regents of the University of Colorado, a body corporate
    Inventors: Kimberly Hassett, Pradyot Nandi, John Carpenter, Theodore Randolph
  • Publication number: 20220193237
    Abstract: The present disclosure provides variant forms of anti-CTLA-4 antibodies, such as ipilimumab, that preferentially bind to CTLA-4 at low pH. Such antibody variants exhibit preferential activity in the tumor microenvironment, an enhanced ratio of anti-tumor response to side-effects, and an enhanced therapeutic index.
    Type: Application
    Filed: April 16, 2020
    Publication date: June 23, 2022
    Inventors: Peter Sung Keun LEE, Pavel STROP, Arvind RAJPAL, Olafur S. GUDMUNDSSON, Pradyot NANDI
  • Publication number: 20210361579
    Abstract: Compositions relating to thermostable vaccines and methods of preparing the same. Specifically, methods of preparing thermostable vaccines based on a recombinant ricin neurotoxin protein and uses of co-adjuvants to develop a composition capable of eliciting an immune response in a subject.
    Type: Application
    Filed: May 10, 2021
    Publication date: November 25, 2021
    Inventors: Kimberly Hassett, Pradyot Nandi, Robert N. Brey, John Carpenter, Theodore Randolph
  • Publication number: 20190380968
    Abstract: The present invention relates generally to the field of immunogenic compositions containing volatile salts. In certain embodiments, compositions and methods disclosed herein relate to producing and using novel combinations to create frozen immunogenic agents bound to adjuvant having improved formulations and improved consistency of distribution of adjuvant for storage and subsequent delivery to a subject in need thereof.
    Type: Application
    Filed: June 21, 2019
    Publication date: December 19, 2019
    Inventors: Kimberly Hassett, Pradyot Nandi, John Carpenter, Theodore Randolph
  • Publication number: 20180092851
    Abstract: Compositions relating to thermostable vaccines and methods of preparing same. Specifically, methods of preparing thermostable vaccines based on a recombinant ricin neurotoxin protein and uses of co-adjuvants to develop a composition capable of eliciting an immune response in a subject.
    Type: Application
    Filed: September 1, 2017
    Publication date: April 5, 2018
    Inventors: Kimberly Hassett, Pradyot Nandi, Robert N. Brey, John Carpenter, Theodore Randolph
  • Publication number: 20130309273
    Abstract: The disclosure provides compositions relating to thermostable vaccines and methods of preparing same. Specifically, the disclosure provides for methods of preparing thermostable vaccines based on a recombinant ricin neurotoxin protein and uses of co-adjuvants to develop a composition capable of eliciting an immune response in a subject.
    Type: Application
    Filed: May 17, 2012
    Publication date: November 21, 2013
    Inventors: Kimberly Hassett, Pradyot Nandi, Robert Brey, John Carpenter, Theodore W. Randolph